TWST:NASDAQ
Twist Bioscience Corp
၁၈၈.၆၇ US$
arrow_upward
+၀.၃၃%(+၀.၆၂) 1D
၁၉၅.၆၉ US$
arrow_upward
+၃.၇၂% (+၇.၀၂)todayPre-market
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
၁၈၈.၇၆ US$
High
၁၉၈.၁၀ US$
Low
၁၈၃.၃၉ US$
Mkt. cap
ဋေ ၁.၂၅ ထ
Avg. vol.
၂.၀၇ သန်း
Volume
၈.၃၉ ထောင်
52-wk high
၂၀၀.၃၁ US$
52-wk low
၂၃.၃၀ US$
EPS
-၂.၂၂ US$
Beta
၂.၁၉
Shares outstanding
၆.၅၈ ကုဋေ
No. of employees
၉၇၉
Open
၁၈၈.၇၆ US$
High
၁၉၈.၁၀ US$
Low
၁၈၃.၃၉ US$
Mkt. cap
ဋေ ၁.၂၅ ထ
Avg. vol.
၂.၀၇ သန်း
Volume
၈.၃၉ ထောင်
52-wk high
၂၀၀.၃၁ US$
52-wk low
၂၃.၃၀ US$
EPS
-၂.၂၂ US$
Beta
၂.၁၉
Shares outstanding
၆.၅၈ ကုဋေ
No. of employees
၉၇၉
News stories
From web sources and news partners
AD HOC NEWS
·
ပြီးခဲ့သည့် ၄ နာရီ
Leerink raises target for Twist Bioscience stock from USD 120 to USD 160
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁၂ နာရီ
Twist Bioscience stock reports 23 percent revenue growth
Stock Traders Daily
·
ပြီးခဲ့သည့် ၂၃ နာရီ
(TWST) as a Liquidity Pulse for Institutional Tactics
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ ရက်
Twist Bioscience (TWST) Stock Fair Value Edges Higher As Analysts Split On AI Upside
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp